Towa Pharmaceutical Co., Ltd.
東和薬品(株)
2026/08/23 Updated
Market Cap:
$1.2B (¥191.7B)
Stock Price:
$24.50 (¥3,895)
Exchange Rate: 1 USD = ¥158.98
【Towa Pharmaceutical】2026 Financial Results｜Sales of 273.7 billion yen, Net profit of 520 million yen (72.3% decrease)
Towa Pharmaceutical's financial results for the fiscal year ending March 2026 show sales of 273.7 billion yen (5.4% increase), but net income attributable to the owners of the parent decreased significantly to 520 million yen (72.3% decrease). The impairment loss on goodwill contributed to the sharp decline in net income.
Key Figures
- Sales: 273.7 billion yen (YoY +5.4%)
- Net income attributable to owners of the parent: 520 million yen (72.3% decrease)
- Ordinary income: 280.7 billion yen (YoY +7.4%)
AI要約
Performance Overview
Future Outlook and Impact on Shareholders
This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.
Towa Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
